REZOLUTE, INC. Convertible Notes Payable, Current
REZOLUTE, INC. (RZLT) had Convertible Notes Payable, Current of $10.00 thousand as of 2019-06-30, per its 10-K filed 2019-09-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleNotesPayableCurrent · last filed 2019-09-10
- 2019-06-30: Convertible Notes Payable, Current $10.00K.
- 2019-03-31: Convertible Notes Payable, Current $10.00K.
- 2018-12-31: Convertible Notes Payable, Current $10.00K.
- 2018-09-30: Convertible Notes Payable, Current $4.14M.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2019-06-30 | $10.00K 10-K · filed 2019-09-10 | |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $10.00K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $4.14M 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $3.44M 10-K · filed 2019-09-10 | $3.43M 10-K · filed 2018-10-15 |
| 2018-03-31 | $924.70K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $10.00K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $10.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.00K 10-K · filed 2018-10-15 | |
| 2017-03-31 | $10.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $10.00K 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $60.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $60.00K 10-K · filed 2017-09-22 | |
| 2016-03-31 | $60.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $60.00K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $60.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $60.00K 10-K · filed 2016-09-28 | |
| 2015-03-31 | $60.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $60.00K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $60.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $60.00K 10-K · filed 2015-09-28 | |
| 2014-03-31 | $657.50K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $3.50M 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $3.73M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $3.73M 10-K · filed 2014-09-30 | |
| 2012-06-30 | $2.14M 10-K · filed 2013-09-11 | |
| 2011-12-31 | $1.16M 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |